Pitavastatin Tablet, Film Coated
Product Images NDC 65862-813

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pitavastatin (NDC 65862-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Pitavastatin Fig1)

Figure (Pitavastatin Fig1)
A forest plot chart titled 'Treatment Difference in Adjusted Mean Percent Change in LDL-C' comparing various doses of Atorvastatin, Simvastatin, and Pravastatin against Pitavastatin at different strengths. The horizontal axis represents treatment difference favoring control or Pitavastatin, with confidence intervals displayed for each study comparison, along with corresponding p-values. The plot illustrates statistical comparisons for LDL-C changes in multiple clinical trials.*
FDA Label Image

Package Label Principal Display Panel (1 mg (90 Tablet Bottle))

Package Label Principal Display Panel (1 mg (90 Tablet Bottle))
Packaging label for Pitavastatin Tablets 1 mg film-coated oral tablets by Aurobindo Pharma Limited. The label indicates a quantity of 90 tablets, includes storage instructions (20° to 25°C), and notes the active ingredient as pitavastatin calcium equivalent to 1 mg pitavastatin per tablet. The label displays NDC 65862-812-90 and distributor information for Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label Principal Display Panel (2 mg (90 Tablet Bottle))

Package Label Principal Display Panel (2 mg (90 Tablet Bottle))
Label for Pitavastatin Tablets 2 mg by Aurobindo Pharma Limited. It contains 90 film-coated tablets with 2.09 mg pitavastatin calcium equivalent to 2 mg pitavastatin. The label includes dosage storage instructions, distributor address in New Jersey, USA, and states the product is made in India. The NDC number 65862-813-90 and barcode are visible.*
FDA Label Image

Package Label Principal Display Panel (4 mg (90 Tablet Bottle))

Package Label Principal Display Panel (4 mg (90 Tablet Bottle))
Pitavastatin Tablets 4 mg film-coated oral tablets packaging label by Aurobindo Pharma Limited. The label states the NDC 65862-814-90 and contains 90 tablets. It describes the active ingredient as pitavastatin calcium equivalent to 4 mg pitavastatin per tablet. Storage instructions, distributor address, and other regulatory information are also included.*
FDA Label Image

Chemical Structure (Pitavastatin Str)

Chemical Structure (Pitavastatin Str)
Chemical structure diagram of Pitavastatin calcium showing its molecular composition and arrangement, including rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.